AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson’s disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions.

For more information visit: www.abbvie.com

The Janssen pharmaceutical companies of Johnson & Johnson. We are part of the one the broadest and most diversified family of healthcare companies – Johnson & Johnson – with a vast array of capabilities that have been honed over 130 years.
We are proud to be recognized for our work. In 2020, for the seventh consecutive year, we were named Number 1 in pharmaceuticals by FORTUNE Magazine’s World’s Most Admired Companies.
Janssen has consistently optimized patient outcomes pioneered new approaches to treating Rheumatological diseases and has a long heritage in developing antibody therapies

For more information visit: www.janssen.com

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 140 nationalities work at Novartis around the world.

For more information visit: www.novartis.com

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its manufacturing expertise to strive for solutions dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be the world’s largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information visit: www.amgen.com

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work.

Across the globe, Lilly employees work to discover and bring lifechanging medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

For more information visit: www.lilly.com

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website

For more information visit: www.pfizer.com

GSK is a leading healthcare company on a mission to help people do more, feel better and live longer. Regionally and globally, we have a proven track-record for providing medicines, vaccines and consumer products. GSK has a 300-year global legacy and more than 65 years of local presence in the GCC, having been providing greater access and innovation to patients and consumers ever since.  In the Gulf region, GSK employs 250 people involved in the regulatory, medical, logistics, supply, research and manufacturing of a broad range of high quality, innovative medicines and vaccines.

For more information visit: www.gsk.com

Sandoz a pioneer and a global leader in biosimilars with over a decade of experience in generic and biosimilar medicines, committed to playing a leading role in driving access to medicine worldwide. Sandoz has a leading biosimilar pipeline and portfolio in immunology, endocrinology and oncology.
At Sandoz, we discover new ways to improve and extend people’s lives and pioneer novel approaches to help people around the world access high-quality medicine. Has a long history of innovating to increase access to high-quality, affordable medicines to millions of patients around the world. We invest in research and development to improve the lives of patients and liberate healthcare resources through increased access to high-quality, affordable biologics.

For more information visit: www.sandoz.com